Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
107.6 USD | -0.77% | -3.81% | +7.08% |
02/07 | ESSILORLUXOTTICA : UBS gives a Buy rating | ZD |
02/07 | ESSILORLUXOTTICA : JP Morgan gives a Buy rating | ZD |
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 33.76 times its estimated earnings per share for the ongoing year.
- The company's enterprise value to sales, at 3.63 times its current sales, is high.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+7.08% | 98.57B | - | ||
+22.24% | 43.85B | B | ||
-8.56% | 17.2B | B- | ||
-30.91% | 1.95B | D+ | ||
+25.22% | 1.16B | - | ||
+73.37% | 675M | - | - | |
-10.11% | 653M | - | ||
-46.03% | 624M | - | ||
-43.74% | 620M | B- | ||
+33.87% | 546M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- EL Stock
- ESLO.Y Stock
- Ratings EssilorLuxottica Société anonyme